Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian Pharma Stocks 

Here are the latest stock price details of India's top Indian Pharma stocks. For more detailed updates, read our Indian Pharma sector report and check the latest Indian Pharma sector results.

Watch Now: Replay of Our Explosive Profits Summit

» Result Scoreboard | Best Performing Stocks | Refresh
SCRIP BSE PRICE (Rs) NSE PRICE (Rs) CHART MORE INFO
AARTI DRUGS 748.75 -0.09% 750.30 0.33%
 More Info 
AJANTA PHARMA 1,598.85 -2.20% 1,605.95 -1.34%
 More Info 
ALEMBIC PHARMA 973.70 -3.75% 973.75 -3.79%
 More Info 
BIOCON 417.20 -2.86% 417.20 -2.90%
 More Info 
CADILA HEALTHCARE 423.85 -0.36% 424.30 -0.32%
 More Info 
CIPLA 756.85 -0.07% 757.55 0.01%
 More Info 
DIVIS LABORATORIES 3,067.25 -0.60% 3,068.85 -0.80%
 More Info 
DR. REDDYS LAB 5,015.90 -0.15% 5,018.25 -0.07%
 More Info 
GLENMARK PHARMA 485.00 -0.38% 485.45 -0.35%
 More Info 
INDOCO REMEDIES 255.10 -1.54% 255.10 -1.77%
 More Info 
IPCA LABS 2,173.00 0.90% 2,175.40 0.92%
 More Info 
J.B.CHEMICALS 999.85 -3.29% 999.35 -2.77%
 More Info 
LUPIN 990.75 -0.20% 991.45 -0.19%
 More Info 
NATCO PHARMA 919.90 0.79% 920.05 0.88%
 More Info 
NIFTY 50 Not Listed 11,930.35 0.28%
 More Info 
ORCHID PHARMA 5.25 -4.89% 18.90 -2.83%
 More Info 
PANACEA BIOTECH 180.20 -0.36% 180.00 -0.58%
 More Info 
PIRAMAL ENTERPRISES 1,327.45 0.58% 1,327.15 0.49%
 More Info 
S&P BSE HEALTHCARE 19,637.28 -0.17% Not Listed
 More Info 
S&P BSE SENSEX 40,685.50 0.31% Not Listed
 More Info 
STRIDES PHARMA SCIENCE 743.45 1.87% 743.10 1.92%
 More Info 
SUN PHARMA 484.35 -0.27% 484.50 -0.22%
 More Info 
TORRENT PHARMA 2,734.35 0.74% 2,733.75 0.69%
 More Info 
WOCKHARDT 294.95 0.39% 294.60 0.37%
 More Info 

BSE prices: October 23, 2020  (Close)    NSE prices: October 23, 2020  (Close)

Indian Pharma Stocks Update

The NIFTY PHARMA Index was at 11,493.6 (down 0.5%). The index is up 11.6% over the last 30 days. And over the last 1 year, it has gained 22.3%.

Within the Indian Pharma sector, the top gainers were STRIDES PHARMA SCIENCE (up 1.9%) and IPCA LABS (up 0.9%). On the other hand, ALEMBIC PHARMA (down 3.8%) and J.B.CHEMICALS (down 3.3%) were among the top losers.

Meanwhile, the benchmark NIFTY 50 was at 11,930.4 (up 0.3%).


What else is happening in the markets today? Dig in...


Today's Market

Sensex Ends 127 Points Higher; Auto Stocks Witness Huge Buying(Closing)

Share markets in India continued to trade on a positive note during closing hours today and ended their session marginally higher.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY21); Net Profit Up 243.5% (Quarterly Result Update)

Sep 29, 2020 | Updated on Sep 29, 2020

For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

CIPLA 2018-19 Annual Report Analysis (Annual Result Update)

Sep 9, 2019 | Updated on Sep 9, 2019

Here's an analysis of the annual report of CIPLA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

More Views on News

Most Popular

My View on ITC (Fast Profits Daily)

Oct 23, 2020

What do the charts say about ITC?

The 'Seedhi Baat, No Bakwaas' View on ITC (Profit Hunter)

Oct 12, 2020

Is ITC an investment or a speculation at current levels?

One of the Best Investment Opportunities in the Market Right Now (Fast Profits Daily)

Oct 16, 2020

The one sector that you should be looking at to make good profits.

Why India's Drone Revolution is a 4x Profit Opportunity (Profit Hunter)

Oct 16, 2020

My research on India's leading defence companies brought me to one major player in drone manufacturing.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE HEALTHCARE


Oct 23, 2020 (Close)

COMPARE COMPANY

MARKET STATS